TACI blockers, such as Atacicept61 and Telitacicept62, might give better responses to SLE in patients of Asian ancestry and recent results of a Phase 2b study showed that the Telitacicept was efficacious for SLE patients in China62. Here, TNFRSF13B is linked to systemic lupus erythematosus.